Arcturus Therapeutics Holdings Inc

Stock Chart, Company Information, and Scan Results

$11.83(as of Oct 23, 1:10 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Arcturus Therapeutics Holdings Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$11.83
Ticker SymbolARCT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees174
CountyUSA
Market Cap$628.9M
EBIDTA-69.3M
10-Day Moving Average19.94
P/E Ratio-5.20
20-Day Moving Average20.34
Forward P/E Ratio2.48
50-Day Moving Average19.07
Earnings per Share-2.22
200-Day Moving Average15.03
Profit Margin-32.44%
RSI31.58
Shares Outstanding27.2M
ATR2.73
52-Week High24.17
Volume15,201,755
52-Week Low8.04
Most Recent Support Level20.40
Book Value231.1M
Most Recent Resistance Level24.17
P/B Ratio1.35
Upper Keltner26.48
P/S Ratio2.66
Lower Keltner14.19
Debt-to-Equity Ratio26.48
Next Earnings Date11/05/2025
Cash Surplus150.0M
Next Ex-Dividend DateUnknown

Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

Arcturus Therapeutics Holdings Inc In Our Stock Scanner

As of Oct 23, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Most Volatile StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.